rawfin.tv
Biodesix Shares Rise 9% Amid Overvaluation Concerns
MarketsstocksAI Generated

Biodesix Shares Rise 9% Amid Overvaluation Concerns

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Biodesix Inc. (BDSX) shares climbed 9.0% to $30.77, extending an upward trend. Despite the rally, GuruFocus data indicates the stock is overvalued with a GF Score of 51/100.

Biodesixstock-performancevaluationbiotech

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks